FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004240143> ?p ?o ?g. }

• W2004240143 endingPage "243" @default.
• W2004240143 startingPage "243" @default.
• W2004240143 abstract "“I would say I've seen two miracles in my clinical experience”, says Paul Krack, head of the Movement Disorder Unit in the Department of Psychiatry and Neurology at University Hospital Grenoble, France. The first was in Paris, in 1993. As a trainee neurologist he attended a meeting of the “Club des Mouvements Anormaux”, where he witnessed a video presentation of the first patient to undergo bilateral subthalamic nucleus (STN) stimulation in Grenoble. Off treatment, the patient was rigid due to Parkinson's disease. But as the switch that controlled the tiny electrode inserted into the patient's brain was flicked on, a seemingly magical transformation took place before the astonished onlookers. “He started getting up, smiling, moving, and that was so impressive”, recalls Krack. “All the people present stood up and applauded; it was a very important moment that I will never forget”. Years later, having devoted much of his career to understanding the effects of STN stimulation on behaviour, Krack saw his second miracle: a patient extremely disabled with what was once seen as a completely non-organic affliction, obsessive compulsive disorder, became free of symptoms after the same type of procedure he had witnessed in Paris. Now, Krack says, the world is poised for a revolution in psychiatry over the coming decades, with psychosurgery increasingly used as an interventional tool. “Today deep brain stimulation [DBS] is totally experimental in psychiatry, but eventually it will become a treatment”, he contends. “I'm working on behaviour in patients with neurological problems and patients with psychiatric problems, and for me there are no borders between the two”. Borders have never been a problem for Krack. When you're born in a country as small as Luxembourg, he says, “you're obliged to learn languages, and that opens up the world”. Although he didn't have to go too far afield for his early training in medicine, opting to cross the border into Germany and the University of Giessen. But it wasn't plain sailing at first. Krack had difficulty applying himself to his studies until he came into contact with his first patient with Parkinson's disease, during a short sabbatical in Birmingham, UK. “That's when I fell in love with neurology”, he recalls, and his passion grew during his training in general neurology back in Giessen. It was during this time that he first encountered Günther Deuschl, an expert on movement disorders at the University of Freiburg; after striking up a friendship, Krack would often consult with Deuschl about his most difficult cases. When Deuschl became a professor at the University of Kiel just as Krack's general training came to an end in 1995, the young man was thrilled to be invited to be part of a new department specialising in movement disorders and DBS. Having witnessed the effects of DBS during that early trip to Paris, Krack was keen to learn more about the technique, and there was one person in particular he was keen to learn from. The patient had been presented by Pierre Pollak, a specialist in experimental treatments for Parkinson's disease at the University of Grenoble. One phone call from Deuschl later, and Krack, along with his wife and young son, was packing his bags for a year in France that would prove pivotal in his career. “That was the best year of my life”, he says. “I could dedicate myself to a couple of patients who I could follow for the full year. Grenoble was absolutely the best place to learn what Parkinson's disease is, and there were so many opportunities to do clinical research”. After returning to Kiel in 1996, Krack helped to build the department into Germany's leading centre for DBS, before a job offer from Pollak tempted him back to Grenoble, where he's been since 2001. Fascinated by the behavioural aspects of Parkinson's disease in particular, Krack studied the role of the basal ganglia and the effects of STN stimulation on emotions. He developed the concept of hyperdopaminergic and hypodopaminergic behaviour, “which is nowadays the concept that is almost unanimously accepted and helps to guide the clinical management of patients with Parkinson's disease”, Deuschl notes. At one end of the behavioural spectrum there is hypodopaminergic behaviour, characterised by a lack of motivation. At the other extreme are the behavioural addictions that stem from a surfeit of motivation. “We are confronted by a continuum of opposite motivational states”, says Krack. “Behaviour determines the quality of life more than the motor aspects of Parkinson's disease” he adds, “and as these dopamine-dependent aspects of behaviour can be influenced, it has become very obvious to me that neurologists must understand the psychology of Parkinson's disease in order to improve patient management”. In the coming years, Krack is determined to play his part in bringing DBS and psychosurgery out of the shadows. “Surgery that changes personality in ‘non-organic’ disease —even if the patient is explicitly asking for it—is confronted by hurdles, not only because of the abuse of psychosurgery in the past, but also because of oppositions between the world of non-biological psychiatry on the one hand and neuroscience on the other hand”, he explains. Trying to reconcile these opposing schools of thought is not a task for the faint hearted, but Krack is more than equal to the job according to Deuschl: “The motor of his actions is not making a career”, he says of his former student, “but solving scientific questions”. Mood and behavioural effects of subthalamic stimulation in Parkinson's diseaseDeep-brain stimulation (DBS) of the subthalamic nucleus (STN) is an established treatment for motor complications in Parkinson's disease. 20 years of experience with this procedure have contributed to improved understanding of the role of the STN in motor, cognitive, and emotional control. In Parkinson's disease, the pathological STN neuronal activity leads to motor, cognitive, and emotional inhibition. Deafferentation of the STN by DBS can reverse such behavioural inhibition. The release of this brake allows both motor and non-motor improvement, but can also be associated with excessive motor, cognitive, and emotional behavioural disinhibition. Full-Text PDF" @default.
• W2004240143 created "2016-06-24" @default.
• W2004240143 creator A5038001468 @default.
• W2004240143 date "2014-03-01" @default.
• W2004240143 modified "2023-10-18" @default.
• W2004240143 title "Paul Krack: deeper brain stimulation" @default.
• W2004240143 doi "https://doi.org/10.1016/s1474-4422(14)70035-3" @default.
• W2004240143 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24556005" @default.
• W2004240143 hasPublicationYear "2014" @default.
• W2004240143 type Work @default.
• W2004240143 sameAs 2004240143 @default.
• W2004240143 citedByCount "0" @default.
• W2004240143 crossrefType "journal-article" @default.
• W2004240143 hasAuthorship W2004240143A5038001468 @default.
• W2004240143 hasBestOaLocation W20042401431 @default.
• W2004240143 hasConcept C126322002 @default.
• W2004240143 hasConcept C15744967 @default.
• W2004240143 hasConcept C169760540 @default.
• W2004240143 hasConcept C24998067 @default.
• W2004240143 hasConcept C2778542668 @default.
• W2004240143 hasConcept C2779134260 @default.
• W2004240143 hasConcept C2779734285 @default.
• W2004240143 hasConcept C2985799443 @default.
• W2004240143 hasConcept C71924100 @default.
• W2004240143 hasConceptScore W2004240143C126322002 @default.
• W2004240143 hasConceptScore W2004240143C15744967 @default.
• W2004240143 hasConceptScore W2004240143C169760540 @default.
• W2004240143 hasConceptScore W2004240143C24998067 @default.
• W2004240143 hasConceptScore W2004240143C2778542668 @default.
• W2004240143 hasConceptScore W2004240143C2779134260 @default.
• W2004240143 hasConceptScore W2004240143C2779734285 @default.
• W2004240143 hasConceptScore W2004240143C2985799443 @default.
• W2004240143 hasConceptScore W2004240143C71924100 @default.
• W2004240143 hasIssue "3" @default.
• W2004240143 hasLocation W20042401431 @default.
• W2004240143 hasLocation W20042401432 @default.
• W2004240143 hasOpenAccess W2004240143 @default.
• W2004240143 hasPrimaryLocation W20042401431 @default.
• W2004240143 hasRelatedWork W2024169567 @default.
• W2004240143 hasRelatedWork W2053600592 @default.
• W2004240143 hasRelatedWork W26188326 @default.
• W2004240143 hasRelatedWork W2791492122 @default.
• W2004240143 hasRelatedWork W2896836670 @default.
• W2004240143 hasRelatedWork W2951735952 @default.
• W2004240143 hasRelatedWork W3102026851 @default.
• W2004240143 hasRelatedWork W4284899459 @default.
• W2004240143 hasRelatedWork W4295926196 @default.
• W2004240143 hasRelatedWork W71768870 @default.
• W2004240143 hasVolume "13" @default.
• W2004240143 isParatext "false" @default.
• W2004240143 isRetracted "false" @default.
• W2004240143 magId "2004240143" @default.
• W2004240143 workType "article" @default.